Mastering 21 CFR Part 11: How Cygnature Bridges the Compliance Gap

Pharma, life sciences, and medical device enterprises today face growing challenges with paper-based approvals, fragmented quality systems, and compliance risks that expose them to FDA Form 483 observations and costly audit delays. It’s time to move from reactive documentation to proactive compliance.

Join us for this exclusive session where industry experts and compliance leaders will walk you through how to achieve effortless 21 CFR Part 11 readiness with Cygnature’s CFR Module: built for data integrity, security, and end-to-end traceability.

• Understand FDA expectations for electronic records, signatures, and audit trails
• Learn how digital signing accelerates approvals from days to minutes
• See how Cygnature secures every step—creator, reviewer, approver—with role-based authentication and timestamped trails
• Watch a live demo of compliant workflows designed for Pharma & Life Sciences
• Discover how enterprises are reducing audit risks while boosting efficiency and reputation

Whether you’re a QA Head, IT/CSV Leader, or Compliance Manager, this session will give you actionable strategies to digitize workflows, prevent audit findings, and future-proof your regulatory landscape.